Sharon Ka Po. Tam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sharon Ka Po. Tam has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Andrew Brodbelt
The Walton Centre, NHS Foundation Trust, UK
2 shared publicationsMansoor Foroughi
Royal Sussex County Hospital, Brighton and Sussex University Hospitals NHS Trust, UK
2 shared publicationsJonathan Chia
Royal Sussex County Hospital, Brighton and Sussex University Hospitals NHS Trust, UK
1 shared publicationPaolo A. Bolognese
Mount Sinai South Nassau, Chiari Neurosurgical Institute, Oceanside, NY, USA
1 shared publication
Latest Publications
- Open Access
- 3 December 2021
- Published by Elsevier in Brain and Spine
- Vol. 2, 100850
Assessment of patients with a Chiari malformation type I
- 3 December 2021
- Published by Elsevier in Brain and Spine
- Vol. 2, 100850
Open AccessAssessment of patients with a Chiari malformation type I
- 23 June 2020
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 163 (1) , 229-238
Posterior fossa decompression with duraplasty in Chiari malformation type 1: a systematic review and meta-analysis
Background Surgery for symptomatic Chiari type I malformation (CM-I) patients include posterior fossa decompression (PFD) involving craniectomy with or without dural opening, and posterior fossa decompression with duraplasty (PFDD). This review aims to examine the evidence to aid surgical decision-making. Methods A medical database search was expanded to include article references to identify all relevant published case series. Animal studies, editorials, letters, and review articles were excluded. A systemic review and meta-analysis were performed to assess clinical and radiological improvement, complications, and reoperation rates. Results Seventeen articles, containing data on 3618 paediatric and adult participants, met the inclusion criteria. In the group, 5 papers included patients that had the dura left open. PFDD is associated with better clinical outcomes (RR 1.24, 95% CI, 1.07 to 1.44; P = 0.004), but has a higher complication rate (RR 4.51, 95% CI, 2.01 to 10.11; P = 0.0003). In adults, clinical outcomes differences did not reach statistical significance (P = 0.07) but re-operation rates were higher with PFD (RR 0.17, 95% CI 0.03 to 0.86; P = 0.03), whilst in children re-operation rates were no different (RR 0.97, 95% CI 0.41 to 2.30; P = 0.94). Patients with a syrinx did better with PFDD (P = 0.02). No significant differences were observed concerning radiological improvement. Conclusions In the absence of hydrocephalus and craniocervical region instability, PFDD provides better clinical outcomes but with higher risk. The use of PFD may be justified in some cases in children, and in the absence of a syrinx. To help with future outcome assessments in patients with a CM-I, standardization of clinical and radiological grading systems are required. Trial registration: not required
- 23 June 2020
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 163 (1) , 229-238
Posterior fossa decompression with duraplasty in Chiari malformation type 1: a systematic review and meta-analysis
Background Surgery for symptomatic Chiari type I malformation (CM-I) patients include posterior fossa decompression (PFD) involving craniectomy with or without dural opening, and posterior fossa decompression with duraplasty (PFDD). This review aims to examine the evidence to aid surgical decision-making. Methods A medical database search was expanded to include article references to identify all relevant published case series. Animal studies, editorials, letters, and review articles were excluded. A systemic review and meta-analysis were performed to assess clinical and radiological improvement, complications, and reoperation rates. Results Seventeen articles, containing data on 3618 paediatric and adult participants, met the inclusion criteria. In the group, 5 papers included patients that had the dura left open. PFDD is associated with better clinical outcomes (RR 1.24, 95% CI, 1.07 to 1.44; P = 0.004), but has a higher complication rate (RR 4.51, 95% CI, 2.01 to 10.11; P = 0.0003). In adults, clinical outcomes differences did not reach statistical significance (P = 0.07) but re-operation rates were higher with PFD (RR 0.17, 95% CI 0.03 to 0.86; P = 0.03), whilst in children re-operation rates were no different (RR 0.97, 95% CI 0.41 to 2.30; P = 0.94). Patients with a syrinx did better with PFDD (P = 0.02). No significant differences were observed concerning radiological improvement. Conclusions In the absence of hydrocephalus and craniocervical region instability, PFDD provides better clinical outcomes but with higher risk. The use of PFD may be justified in some cases in children, and in the absence of a syrinx. To help with future outcome assessments in patients with a CM-I, standardization of clinical and radiological grading systems are required. Trial registration: not required